Carol Garrean
Internal Medicine · Fort Wayne, INNPI 1013179357
Payments from drug & device makers
Across 79 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$318
- Lilly USA, LLC$253
- Amgen$119
- Abbott$98
- Boehringer Ingelheim$73
- Sanofi-aventis U.S. LLC$67
- plus $356 from 16 others
What the payments were for
- Food & beverage$1,284100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $318 |
| Lilly USA, LLC | 7 | $253 |
| Amgen | 2 | $119 |
| Abbott | 6 | $98 |
| Boehringer Ingelheim | 5 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| AstraZeneca | 3 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Pfizer | 3 | $35 |
| GSK | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,284 in reported general payments places this provider in the 75th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 116 | $165,589 |
| EliquisApixaban | 55 | $82,920 |
| OzempicSemaglutide | 29 | $46,251 |
| JardianceEmpagliflozin | 30 | $42,405 |
| XareltoRivaroxaban | 16 | $24,988 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $24,482 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $19,510 |
| JanuviaSitagliptin Phosphate | 13 | $17,028 |
| MyrbetriqMirabegron | 13 | $12,269 |
| RybelsusSemaglutide | 12 | $12,121 |
| Tresiba Flextouch U-100Insulin Degludec | 30 | $10,653 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $10,073 |
| Incruse ElliptaUmeclidinium Bromide | 22 | $7,805 |
| BelsomraSuvorexant | 12 | $6,311 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,849 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $253 | $165,589116 claims |
| PfizerEliquis | $35 | $82,92055 claims |
| Novo NordiskOzempic, Rybelsus | $318 | $58,37241 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta | $30 | $51,79783 claims |
| Boehringer IngelheimJardiance | $73 | $42,40530 claims |
| Johnson & JohnsonXarelto | $20 | $24,98816 claims |
| Astellas Pharma US IncMyrbetriq | $21 | $12,26913 claims |
| AstraZenecaSymbicort | $61 | $5,84914 claims |
| AbbVieSynthroid | $15 | $1,91833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Fort Wayne
- David IloFort Wayne$86K
- Anuradha KolliparaFort Wayne$30K
- Sumona KabirFort Wayne$28K
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.